Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial - de Boer, SM; Powell, SE; Mileshkin, L (Lancet Oncol, 2019)
et al.